ARCHIVES

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 40 | October 20, 1995

Download PDF Visit The Full Archive

Related Articles

NCI Plans Brain Tumor Study To Determine Risk Factors, Exposures

April 16, 1993

DCBD Board Okays Concept For New Cytogenetics RFA

August 3, 1984

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

June 27, 2014

In Brief: Arlan Gottlieb, CALGB Leader, Dead At 55; NCI’s John Cooper Undergoes Heart Transplant

July 7, 1989

Steiner To Leave ICC, Says Someone Else May Do Better

December 10, 1982

Organ Site Grants Fare Badly In NIH Study Section Review; RPMI, UT Galveston, Rush Compete For HQ

October 21, 1983